1,051 results on '"Schöder, Heiko"'
Search Results
2. [18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
3. Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
4. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
5. Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop.
6. Tumors Affect the Metabolic Connectivity of the Human Brain Measured by 18F-FDG PET
7. Architecture of the outbred brown fat proteome defines regulators of metabolic physiology
8. Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis.
9. Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups
10. Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis
11. Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
12. Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis
13. Polyethylene Glycol 3350 (PEG 3350) as a Practical Vehicle for Rapid Reconstitution of PARPi-FL Formulations for Clinical Use
14. A comprehensive review of imaging findings in COVID-19 - status in early 2021.
15. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)
16. Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
17. Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial
18. Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
19. Retrospective characterization of nodal marginal zone lymphoma
20. Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
21. Radiotheranostics in oncology: current challenges and emerging opportunities
22. Teaching Cases in Nuclear Oncology: Testicular Cancer
23. Teaching Cases in Nuclear Oncology: Penile Cancer
24. Teaching Cases in Nuclear Oncology: Lymphomas
25. Teaching Cases in Nuclear Oncology: Thyroid Tumors
26. Teaching Cases in Nuclear Oncology: Parathyroid Tumors
27. Teaching Cases in Nuclear Oncology: Multiple Myeloma
28. Teaching Cases in Nuclear Oncology: Head and Neck Cancers
29. Diagnostic Applications of Nuclear Medicine: Head and Neck Cancer
30. Intra-treatment hypoxia directed major radiation de-escalation as definitive treatment for human papillomavirus-related oropharyngeal cancer.
31. The combination of patient-specific tumor and HPV sequencing to enable high-sensitivity detection of ctDNA in patients with HPV-associated oropharyngeal carcinoma.
32. Induction chemotherapy effects on very advanced (T3/T4) human papillomavirus-related oropharyngeal cancer for participation in hypoxia-directed major de-escalation (30 Gy) definitive treatment trial.
33. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
34. TriDFusion (3DF) image viewer
35. Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer
36. [18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
37. Machine Learning for Automated Interpretation of Fluorodeoxyglucose-Positron Emission Tomography Scans in Lymphoma.
38. Tumors Affect the Metabolic Connectivity of the Human Brain Measured by 18F-FDG PET.
39. International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.
40. Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies
41. An Analysis of Positron Emission Tomography Maximum Standard Uptake Value Among Patients With Head and Neck Cancer Receiving Photon and Proton Radiation
42. Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations
43. Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers
44. A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer
45. Brown adipose tissue is associated with healthier body fat distribution and metabolic benefits independent of regional adiposity
46. PET imaging in renal and bladder cancers
47. [89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma
48. A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging
49. A pilot study of 13N-ammonia cardiac PET imaging to assess subacute cardiotoxicity following adjuvant intensity-modulated radiotherapy for locally advanced breast cancer
50. EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.